Anygen Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
85
- Stock Symbol
-
196300
- Share Price
-
$6.16
- (As of Wednesday Closing)
Anygen General Information
Description
AnyGen Co Ltd is a bio-venture company. The Company manufactures peptide APIs and new drug development. It offers GMP peptides, Generic peptides, Custom peptides, Catalog peptides and other services.
Contact Information
Website
www.anygen.comCorporate Office
- Gwangju Techno Park Test Production Building
- Suite 206, 333 Cheomdan Gwagi-ro, Buk-gu
- Gwangju, 61008
- South Korea
Corporate Office
- Gwangju Techno Park Test Production Building
- Suite 206, 333 Cheomdan Gwagi-ro, Buk-gu
- Gwangju, 61008
- South Korea
Anygen Stock Performance
As of 26-Mar-2025, Anygen’s stock price is $6.16. Its current market cap is $57.2M with 9.3M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.16 | $6.16 | $3.86 - $12.95 | $57.2M | 9.3M | 263K | -$1.10 |
Anygen Financials Summary
As of 30-Sep-2024, Anygen has a trailing 12-month revenue of $4.55M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 59,944 | 71,906 | 36,784 | 74,184 |
| Revenue | 4,545 | 4,291 | 6,704 | 8,963 |
| EBITDA | (4,245) | (4,138) | (1,924) | 1,943 |
| Net Income | (6,443) | (6,944) | (4,802) | (1,475) |
| Total Assets | 13,619 | 16,292 | 20,498 | 27,239 |
| Total Debt | 5,697 | 5,702 | 6,678 | 6,740 |
Anygen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Anygen Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Anygen Patents
Anygen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022342994-A9 | Composition for preventing or treating inflammatory bowel disease containing novel compound | Active | 09-Sep-2021 | ||
| CA-3219189-A1 | Composition for preventing or treating inflammatory bowel disease containing novel compound | Pending | 09-Sep-2021 | ||
| AU-2022342994-A1 | Composition for preventing or treating inflammatory bowel disease containing novel compound | Active | 09-Sep-2021 | ||
| EP-4317171-A4 | Composition for preventing or treating inflammatory bowel disease containing novel compound | Pending | 09-Sep-2021 | ||
| EP-4317171-A1 | Composition for preventing or treating inflammatory bowel disease containing novel compound | Pending | 09-Sep-2021 | A23L33/18 |
Anygen Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Anygen FAQs
-
When was Anygen founded?
Anygen was founded in 2000.
-
Where is Anygen headquartered?
Anygen is headquartered in Gwangju, South Korea.
-
What is the size of Anygen?
Anygen has 85 total employees.
-
What industry is Anygen in?
Anygen’s primary industry is Biotechnology.
-
Is Anygen a private or public company?
Anygen is a Public company.
-
What is Anygen’s stock symbol?
The ticker symbol for Anygen is 196300.
-
What is the current stock price of Anygen?
As of 26-Mar-2025 the stock price of Anygen is $6.16.
-
What is the current market cap of Anygen?
The current market capitalization of Anygen is $57.2M.
-
What is Anygen’s current revenue?
The trailing twelve month revenue for Anygen is $4.55M.
-
What is Anygen’s annual earnings per share (EPS)?
Anygen’s EPS for 12 months was -$1.10.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
